Skip to main content

Alpine Immune Sciences, Inc.

ALPNDelisted May 20, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001626199

Alpine Immune Sciences, Inc. was delisted on May 20, 2024; its insiders filed their last Form 4 on May 20, 2024; 180 institutions reported holding it in 13F filings for Q1 2024, worth $2.56B in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding Alpine Immune Sciences, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of ALPN: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders7788+11
Shares43.7M45.9M+2.22M (+5.1%)
Value$449.3M$525.8M+$76.6M (+17.0%)

New holders (16)

Institutions that held Alpine Immune Sciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to ALPN in Q3 2023
InstitutionSharesValue% of portfolio
Cormorant Asset Management, LP1,900,000$21.8M1.27%
Invesco Ltd.217,136$2.49M0.00%
Nan Fung Group Holdings Ltd182,280$2.09M1.69%
D. E. Shaw & Co., Inc.48,631$556.8K0.00%
Swiss National Bank42,200$483.2K0.00%
Wellington Management Group LLP39,731$454.9K0.00%
State of Wisconsin Investment Board22,197$254.2K0.00%
Algert Global LLC20,010$229.1K0.01%
Driehaus Capital Management LLC18,636$213.4K0.00%
Jane Street Group, LLC18,198$208.4K0.00%
Credit Suisse AG15,209$174.1K0.00%
Qube Research & Technologies Ltd10,070$115.3K0.00%
SG Americas Securities, LLC9,927$114.0K0.00%
Allspring Global Investments Holdings, LLC176$2.02K0.00%
Aquatic Capital Management LLC200$2.00K0.00%
GWM Advisors LLC125$1.43K0.00%

Sold out (5)

Institutions that held Alpine Immune Sciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of ALPN in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
TCG Crossover Management, LLC253,069$2.60M
Affinity Asset Advisors, LLC118,891$1.22M
Westwood Holdings Group Inc.43,799$450.0K
Panagora Asset Management Inc12,394$127.4K
Susquehanna International Group, LLP11,451$117.7K